NASDAQ · Biotechnology

MetaVia Inc. (MTVA) Stock

$1.32 -4.35% NASDAQ: MTVA Healthcare

Valuation

MetricValue
Price$1.32
Market Cap$8.70M
P/E Ratio-0.38
P/B Ratio1.34
P/S Ratio0.00
EPS (TTM)$-7.35
52-Week High$14.85
52-Week Low$0.97
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-209.67%
ROA-108.85%
ROCE-215.61%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.03
Current Ratio1.83

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-15.0M$-20.0M$-16.0M$-29.0M$-14.0M
Net Profit$-15.0M$-14.0M$-12.0M$-28.0M$-13.0M
EPS$-1742.40$-477.84$-27.06$-39.16$-7.35
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$17.0M$34.0M$23.0M$16.0M$69.0M
Total Liabilities$2.0M$12.0M$6.0M$8.0M$64.0M
Cash$16.0M$33.0M$22.0M$16.0M$10.0M
Borrowings$0$0$0$0$0

Latest News

Sector Update: Healthcare Stocks Softer Late Afternoon MT Newswires · Jul 9, 2026 Sector Update: Healthcare Stocks Decline in Afternoon Trading MT Newswires · Jul 9, 2026 MetaVia Says Patients on Experimental Obesity Drug Reach Highest Target Doses in Phase 1 Trial MT Newswires · Jul 9, 2026 MetaVia Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity PR Newswire · Jul 9, 2026 OTC Markets Life Sciences Investor Forum: MetaVia CEO HH Kim and CFO Marshall Woodworth with Zacks SCR's David Bautz Zacks Small Cap Research · Jun 30, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-15.0M$-12.0M$-11.0M$-25.0M$-16.0M
Investing Cash Flow$-1.0M$0$0$0$0
Financing Cash Flow$-2.0M$-36.0M$0$-2.0M$0
Net Cash Flow$6.0M$17.0M$-11.0M$-6.0M$-6.0M
Free Cash Flow$-15.0M$-12.0M$-11.0M$-25.0M$-16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.16
FCF Yield-156.08%
Quick Ratio2.06
Interest Coverage—
Return 1Y-74.82%
Return 3Y-95.19%
Return 5Y-99.97%

Ownership

Insiders Held36.50%
Institutions Held13.38%
Institutions Float Held21.07%
Institutional HolderSharesReport Date
Geode Capital Management, LLC33,6352026-03-31
Jane Street Group, LLC10,9032026-03-31
Aries Wealth Management10,0002026-03-31
Vanguard Fiduciary Trust Co6,9402026-03-31
Tower Research Capital LLC (TRC)2,6022026-03-31

About MetaVia Inc.

MetaVia Inc. is led by CEO Hyung Heon Kim, employs 9 people, headquartered in US, publicly traded since 2016.

MetaVia Inc. (MTVA) stock trades at $1.32 with a market capitalization of $8.70M. The stock is valued at a negative price-to-earnings (P/E) ratio of -0.38, reflecting a net loss over the last twelve months, price-to-book of 1.34, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.97 and $14.85, and currently trades 91.1% below its 52-week high.

On profitability, MetaVia Inc. generates a return on equity (ROE) of -209.67% (negative, reflecting a net loss), return on capital employed of -215.61%.

MetaVia Inc. by the numbers, 2016–2025

Between 2016 and 2025 MetaVia Inc. reported revenue of $0 rising to $0. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit rose to $-13.0M.

On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $-14.0M.

Borrowings stand at $0, cash from operations was $-16.0M in the latest year, positive in 0 of the last 10.

Return on equity has averaged -168.8% over five years, and was -260.0% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

MetaVia Inc. (MTVA) — frequently asked questions

What is MetaVia Inc. (MTVA) stock price today?

MetaVia Inc. (MTVA) is currently trading at $1.32, down 4.35% today.

What is MTVA P/E ratio?

MetaVia Inc.'s P/E ratio is -0.38. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.

What is MTVA return on equity (ROE)?

MetaVia Inc.'s return on equity (ROE) is -209.67%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is MetaVia Inc.'s market cap?

MetaVia Inc. has a market capitalization of $8.70M.

Does MTVA pay a dividend?

MetaVia Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does MTVA carry?

MetaVia Inc. has a debt-to-equity ratio of 0.03. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is MTVA's profit margin?

MetaVia Inc. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.

What sector is MTVA in?

MetaVia Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is MTVA listed on?

MetaVia Inc. trades on NASDAQ under the ticker MTVA.

What is MTVA's 52-week range?

Over the last year MetaVia Inc. has traded between $0.97 and $14.85.

Related Healthcare Stocks

LLY Eli Lilly and Company $1275.99 +0.20% JNJ Johnson & Johnson $265.85 +0.77% ABBV AbbVie Inc. $286.55 +0.32% UNH UnitedHealth Group Incorporated Common Stock (DE) $412.19 -1.41% MRK Merck & Company, Inc. Common Stock (new) $142.04 -2.22% NVS Novartis AG $153.41 +1.52% AZN AstraZeneca PLC $171.11 -0.22% TMO Thermo Fisher Scientific Inc $680.64 +1.01% AMGN Amgen Inc. $440.91 +0.38% GILD Gilead Sciences, Inc. $158.35 +1.48% ABT Abbott Laboratories $104.86 +1.11% NVO Novo Nordisk A/S $38.99 -0.15%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens MTVA currently matches

On the figures above, MetaVia Inc. passes the filters for 3 of our ready-made screens, among them Penny Stocks, Debt Free Stocks Under $100, Nano Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Penny StocksDebt Free Stocks Under $100Nano Cap Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.